The Active Pharmaceutical Ingredients Market is expected to grow at a CAGR of over 4% during the forecast period (2021-2031)


NEW YORK, June 10, 2021 / PRNewswire / – The active pharmaceutical ingredients are drugs used for chronic diseases such as neuropathic pain, lung disease, cancer, diabetes and heart disease. However, these ingredients have both benefits and side effects.

Pharmaceutical companies have focused on modernizing their manufacturing methods to improve the overall quality of products. It also means automating process development, which was previously done manually. The installation of large capacity equipment in terms of volume also allows for better production efficiency.

According to the revised report published by Persistence Market Research, the global active pharmaceutical ingredients market is valued at approximately US $ 180 billion in 2020, and is expected to increase at a CAGR of over 4% during the forecast period (2021-2031).

Key points of the market research

  • Small molecule active pharmaceutical ingredients are expected to contribute over 91% of market revenue by 2031, due to their high availability and potency in relieving moderate to severe pain, typically after surgery or traumatic injury .
  • Uncontrolled substances are expected to account for more than half of the global market share.
  • Among all end users, pharmaceutical companies accounted for more market share than others.
  • East Asia holds the highest share of the global active pharmaceutical ingredients market, owing to the presence of more CMOs, high healthcare expenditure and increasing research and development efforts in the region.
  • Major players are focused on strengthening their clinical pipelines with new discoveries of new abuse deterrent formulations.
  • The market in the India is expected to increase at a CAGR of around 4% through 2021-2031. The United States holds a large chunk of global revenue and accounts for over 87% of the world’s shares. North America Marlet.

Request a sample PDF report:

“There is strong growth in demand for small molecules, due to their potency, efficacy and safety,” says a Persistence Market Research analyst.

Increased healthcare expenditure on active pharmaceutical ingredients

Global healthcare spending grew at a CAGR of 6.92% from 2003 to 2013. This growth in healthcare spending far exceeded the rate of population growth during this period, which increased at a CAGR of 1 , 22%. As a result, per capita health expenditure has increased from 597 USD in 2003 to $ 1,032 in 2013, increasing at a CAGR of 5.62%.

Know the reporting methodology by asking an expert:

Increased health spending in all regions has improved access to quality health care and is expected to continue to drive demand for pharmaceuticals.

  • At March 25, 2019, TUL secured its position in the TOP 10 of API member companies in China in 2018. The position was awarded to TUL for its excellent export and import profile of APIs, pharmaceutical formulations and Chinese medicines in 2018.
  • In 2016, Sandoz from Novartis ceased operations in its Maharashtra, India site, as part of overall manufacturing optimization plans. The site, located in the center-west India, employed 170 people and manufactured antibiotics and APIs.

Get full access to the report:

What does the report cover?

Persistence Market Research provides a unique perspective and actionable insights into the Active Pharmaceutical Ingredients market in its latest study, presenting a historical demand assessment for 2016-2020 and projections for 2021-2031. The research study is based on API (small molecules, peptides and oligonucleotides, carbohydrates and steroid drugs) and end user (contract manufacturing organizations (CMOs), pharmaceutical companies, development manufacturing organizations under contract (CDMO) and preparation pharmacies), in seven key regions of the world.

Browse the research release on:

Browse the market from start to finish: Health care

Associated reports:

On Persistence market research


Persistence Market Research (PMR) is a third-platform research company. Our research model is a unique collaboration of data analysis and market research methodology to help companies achieve peak performance.

To help companies overcome complex business challenges, we take a multidisciplinary approach. At PMR, we unite various data streams from multidimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.


Rajendra singh
Persistence market research
US Sales Office:
305 Broadway, 7th Floor
New York City, NY 10007
+ 1-646-568-7751
United States
United States – Canada Toll Free: 800-961-0353
E-mail: [email protected]
Visit our website:

SOURCE Persistence Market Research Pvt. Ltd.


Leave A Reply